• Explore /
  • Poster
  • / Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.

Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.

Abstract Poster

Authors

null

Michael Michael

Peter MacCallum Cancer Centre, East Melbourne, Australia

Michael Michael , Mary Frances Mulcahy , Dustin A. Deming , Houman Vaghefi , Gayle S. Jameson , Angela DeLuca , Hao Xiong , Wijith Munasinghe , Matthew W. Dudley , Philip Komarnitsky , Kyle D. Holen , Brian G. Czito

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT01589419

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3517)

DOI

10.1200/jco.2015.33.15_suppl.3517

Abstract #

3517

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Brian G. Czito

First Author: Brian G. Czito

First Author: Paul Bernard Romesser

First Author: Paul Bernard Romesser